Open Access

MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells

  • Authors:
    • Zhan Wang
    • Min Zhang
    • Rong Shan
    • Yu‑Jie Wang
    • Juan Chen
    • Juan Huang
    • Lun‑Quan Sun
    • Wei‑Bing Zhou
  • View Affiliations

  • Published online on: August 23, 2019     https://doi.org/10.3892/or.2019.7292
  • Pages: 1915-1923
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

As a member of the myotubularin family, myotubularin related protein 3 (MTMR3) has been demonstrated to participate in tumor development, including oral and colon cancer. However, little is known about its functional roles in breast cancer. In the present study, the expression of MTMR3 in breast cancer was evaluated by immunohistochemical staining of tumor tissues from 172 patients. Online data was then used for survival analysis from the PROGgeneV2 database. In vitro, MTMR3 expression was silenced in MDA‑MB‑231 cells via lentiviral shRNA transduction. MTT, colony formation and flow cytometry assays were performed in the control and MTMR3‑silenced cells to evaluate the cell growth, proliferation and cell cycle phase distribution, respectively. Western blotting was used to evaluate the protein expression levels of autophagy‑related markers. The results demonstrated that the expression of MTMR3 in breast cancer tissues was significantly increased compared with adjacent normal tissues. MTMR3 was highly expressed in triple‑negative breast cancer and was associated with disease recurrence. MTMR3 knockdown in MDA‑MB‑231 cells inhibited cell proliferation and induced cell cycle arrest and autophagy. The present results indicated that MTMR3 may have an important role in promoting the progression of breast cancer, and its inhibition may serve as a promising therapeutic target for breast cancer treatment.
View Figures
View References

Related Articles

Journal Cover

November-2019
Volume 42 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Z, Zhang M, Shan R, Wang YJ, Chen J, Huang J, Sun LQ and Zhou WB: MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells. Oncol Rep 42: 1915-1923, 2019
APA
Wang, Z., Zhang, M., Shan, R., Wang, Y., Chen, J., Huang, J. ... Zhou, W. (2019). MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells. Oncology Reports, 42, 1915-1923. https://doi.org/10.3892/or.2019.7292
MLA
Wang, Z., Zhang, M., Shan, R., Wang, Y., Chen, J., Huang, J., Sun, L., Zhou, W."MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells". Oncology Reports 42.5 (2019): 1915-1923.
Chicago
Wang, Z., Zhang, M., Shan, R., Wang, Y., Chen, J., Huang, J., Sun, L., Zhou, W."MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells". Oncology Reports 42, no. 5 (2019): 1915-1923. https://doi.org/10.3892/or.2019.7292